Results 71 to 80 of about 369,907 (149)

Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study. [PDF]

J Viral Hepat
Badia L, Ciancio A, Distefano M, Izzi A, Loglio A.   +4 more
europepmc   +1 more source

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm. [PDF]

Liver Int
Caviglia GP, Dileo E, Olivero A, Mengozzi G, Ciancio A, Loglio A, Viganò M, Fagiuoli S, Colombatto P, Coco B, Brunetto MR, Angrisani D, Galeota Lanza A, Magni C, Rizzardini G, Messina V, Milella M, Saracino A, Marinaro L, Cariti G, Cossiga V, Morisco F, Cretella S, Verucchi G, Biliotti E, D'Offizi G, Feasi M, Pontali E, Coppola C, Rapetti R, Pirisi M, Izzi A, Santantonio T, Di Marco V, Marrone A, Coppola N, Rizzi M, Cattelan AM, Niro GA, Toniutto P, Ponziani FR, Belli LS, Federico A, Bertino G, Barone M, Puoti M, Civolani A, Distefano M, Surace LA, Cozzolongo R, Cela EM, Teti E, Lampertico P, Stroffolini T, Rizzetto M, HDV Describe Study Group.   +55 more
europepmc   +1 more source

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D. [PDF]

Liver Int
Herta T, Dietz-Fricke C, Demir M, Sprinzl K, Pfeiffer KH, Grottenthaler JM, Buggisch P, Kremer WM, Reiter FP, Geier A, Schramm C, Merle U, Neumann-Haefelin C, Tacke F, Berg T, Wedemeyer H, Deterding K, Wiegand J.   +17 more
europepmc   +1 more source

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D). [PDF]

Open Forum Infect Dis
Ingiliz P, Vo-Quang E, Ndow G, Lemoine M, Ceesay A, Drammeh S, Hilleret MN, Bordy L, Decaens T, Mazialivoua AL, Shimakawa Y, Touray AB, Pawlotsky JM, Chemin I, Chevaliez S, Leroy V.   +15 more
europepmc   +1 more source

Prevalence of Hepatitis D and Its Impact on the Clinical Efficacy of Antiretroviral Therapy in People With HBV/HIV-1 in Guangdong Province, China. [PDF]

Open Forum Infect Dis
He Y, Lin W, Li H, Gu F, Lan X, Liu X, Zhang Y, Li R, He R, Cai W, Tang X, Li L.   +11 more
europepmc   +1 more source

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany. [PDF]

Infection
Elamouri F, Lutz T, Knecht G, Wyen C, Posdzich P, Monin M, Sabranski M, Hoffmann C, Killer A, Jensen BE, Malin JJ, Esser S, Mauss S, Vogelmann R, Boesecke C, Beer D, Grunwald S, Haberl A, Voit F, Qurishi N, Noe S, Khaykin P, Schneeweiß SM, Christensen S, Schwarze-Zander C, Jessen A, Boyd A, Rockstroh JK, van Bremen K.   +28 more
europepmc   +1 more source

Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. [PDF]

Lancet Oncol
Karagas MR, Kaldor J, Michaelis M, Muchengeti MM, Alfaiate D, Argirion I, Chen X, Cunha C, Hantz S, Koljonen V, Laude HC, Lui WO, Nevels MM, O'Brien TR, Scheurer ME, Touze A, Wiemels JL, Benbrahim-Tallaa L, de Conti A, Facchin C, Madia F, Pasqual E, Wedekind R, Aguilera-Buenosvinos I, Clifford G, Deng X, Dongoran RA, Ezzemni S, Huang Y, Suonio E, Zhai Y, Mattock H, Schubauer-Berigan MK, Kunzmann AT.   +33 more
europepmc   +1 more source

Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment. [PDF]

J Virol
Ding Y, Li Q, Sha Y, Si R, Feng C, Liu M, Feng Z, Ding X, Li Y, Fu H, Liang S, Yao Q, Zhang Z, Li F, Urban S, Guo H, Wang W.   +16 more
europepmc   +1 more source

A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. [PDF]

J Clin Microbiol
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, Gómez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP.   +11 more
europepmc   +1 more source